Crispr Therapeutics (CRSP) Job Posts Statistics 2024

70%

1W 12.5% 1M 0% 3M 56.3%

Est. open job positions.

Similar companies

Company		Job Posts
	Amgen AMGN	782
	Gilead Sciences GILD	346
	Catalyst Pharmaceuticals CPRX	3
	Inovio Pharmaceuticals INO	4
	Anavex Life Sciences AVXL	0

Month over Month

Est. open job positions.

Oct 2024	9	31.4%
Sep 2024	13	9.5%
Aug 2024	15	7.8%
Jul 2024	14	26.6%
Jun 2024	11

How many positions are open at Crispr Therapeutics?

Crispr Therapeutics has, according to data from the most popular job boards, 7 open positions.

Analyzing Job Posts, how is Crispr Therapeutics performing compared to its industry peers?

Crispr Therapeutics underperforms its industry peers when it comes to Job Posts, ranking dead last.

How has job posts from Crispr Therapeutics changed over time?

Job postings by Crispr Therapeutics are trending down in the last couple of months. This could indicate a slowdown or an ambition to improve margins.

Why is it important to track open positions at Crispr Therapeutics?

Tracking job postings is important because an increase in job postings can indicate future growth, while a decrease suggests a slowdown or cost-cutting measures. When combined with other indicators, analyzing job postings can help investors assess the future prospects of Crispr Therapeutics.

About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.